Wiley → Amazon

Reported Terms

Not disclosed, but AInvest estimated that "Subscription-based access to the AI toolkit could add $100–$150 million annually to Wiley’s top line by 2027" — Not disclosed

Notes

AWS has built an open source toolkit for healthcare and life sciences, which "offers a catalog of starter agents and an orchestration framework for organizations to build and customize their agentic systems, supporting use cases from biomarker discovery to clinical trial protocol generation." Until this point, the toolkit relied on open source content. | It appears that in order to use the Wiley agent within the broader AWS toolkit, users will pay an additional subscription fee. This is an interesting model similar to Wiley's Perplexity deal, as it is packaged as an optional enhancement to an existing system where the end user pays for athe additional content. The press release also stresses the full text search component of this agentic model heavily (in contrast to more common abstract-only search models). In Wiley's 2025 Quarter 1 Earnings Call, Wiley's AI licensing strategy was described as a two-part model: "We see the content licensing opportunity in two stages. The first as discussed is participating in the near-term development of foundational models. The second is in recurring licensing arrangements over the medium to long term, as these models and applications come online and as information-centric corporates bring our content into their AI environments."

Sources